{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T03:29:01Z","timestamp":1767842941271,"version":"3.49.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,7,3]],"date-time":"2012-07-03T00:00:00Z","timestamp":1341273600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1007\/s12253-012-9551-7","type":"journal-article","created":{"date-parts":[[2012,7,2]],"date-time":"2012-07-02T14:27:34Z","timestamp":1341239254000},"page":"119-122","source":"Crossref","is-referenced-by-count":9,"title":["Successful Treatment of Solitary Bone Metastasis of Non-Small Cell Lung Cancer with Bevacizumab and Hyperthermia"],"prefix":"10.1007","volume":"19","author":[{"given":"G\u00e1bor","family":"Rubovszky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T\u00fcnde","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e1ria","family":"G\u0151d\u00e9ny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e1s","family":"Sz\u00e1sz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Istv\u00e1n","family":"L\u00e1ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,7,3]]},"reference":[{"key":"9551_CR1","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1002\/cncr.21869","volume":"06","author":"HA Wakelee","year":"2006","unstructured":"Wakelee HA, Bernardo P, Johnson DH et al (2006) Changes in the natural history of nonsmall cell lung cancer (NSCLC)\u2013comparison of outcomes and characteristics in patients with advanced NSCLC entered in Eastern Cooperative Oncology Group trials before and after 1990. Cancer 06:2208\u20132217","journal-title":"Cancer"},{"key":"9551_CR2","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1378\/chest.128.1.452","volume":"28","author":"P Yang","year":"2005","unstructured":"Yang P, Allen MS, Aubry MC et al (2005) Clinical features of 5,628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003. Chest 28:452\u2013462","journal-title":"Chest"},{"key":"9551_CR3","doi-asserted-by":"crossref","first-page":"4539","DOI":"10.1200\/JCO.2005.04.4859","volume":"24","author":"R Govindan","year":"2006","unstructured":"Govindan R, Page N, Morgensztern D et al (2006) Changing epidemiology of small-cell lung cancer in the United States over the last 30\u00a0years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol 24:4539\u20134544","journal-title":"J Clin Oncol"},{"key":"9551_CR4","doi-asserted-by":"crossref","first-page":"6251","DOI":"10.1200\/JCO.2009.23.5622","volume":"27","author":"CG Azzoli","year":"2009","unstructured":"Azzoli CG, Baker S, Temin S et al (2009) American Society of Clinical Oncology Clinical Practice guideline update on chemotherapy for Stage IV non-Nmall-Cell Lung Cancer. J Clin Oncol 27:6251\u20136266","journal-title":"J Clin Oncol"},{"key":"9551_CR5","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1056\/NEJMoa061884","volume":"355","author":"A Sandler","year":"2006","unstructured":"Sandler A, Gray R, Perry MC (2006) Paclitaxel\u2013carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med 355:2542\u20132550","journal-title":"N Engl J Med"},{"key":"9551_CR6","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1200\/JCO.2007.14.5466","volume":"27","author":"M Reck","year":"2009","unstructured":"Reck M, von Pawel J, Zatloukal P (2009) Phase iii trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: avail. J Clin Oncol 27:1227\u20131234","journal-title":"J Clin Oncol"},{"issue":"Suppl 1","key":"9551_CR7","first-page":"S359","volume":"4","author":"J Laskin","year":"2009","unstructured":"Laskin J, Crin\u00f2 L, Tsai C (2009) MO19390 (SAIL): first-line bevacizumab-based therapy in advanced non-small cell lung cancer (nsclc)\u2014outcome by chemotherapy regimen [abstract C2.5]. J Thorac Oncol 4(Suppl 1):S359","journal-title":"J Thorac Oncol"},{"issue":"suppl 2","key":"9551_CR8","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.3816\/CLC.2008.s.010","volume":"9","author":"V Hirsh","year":"2008","unstructured":"Hirsh V (2008) Emerging safety data for bevacizumab in advanced non\u2013small-cell lung cancer. Clin Lung Cancer 9(suppl 2):S62\u2013S70","journal-title":"Clin Lung Cancer"},{"key":"9551_CR9","first-page":"417s","volume":"27","author":"L Crin\u00f2","year":"2009","unstructured":"Crin\u00f2 L, Mezger J, Griesinger F et al (2009) MO19390 (SAIL): safety and efficacy of first-line bevacizumab (Bv)-based therapy in advanced non-small cell lung cancer (nsclc) [abstract 8043] Proc Am Soc. Clin Oncol 27:417s","journal-title":"Clin Oncol"},{"key":"9551_CR10","first-page":"416s","volume":"27","author":"N Fischbach","year":"2009","unstructured":"Fischbach N, Spigel D, Brahmer J, on behalf of the ARIES investigators (2009) Preliminary safety and effectiveness of bevacizumab (bv) based treatment in subpopulations of patients (pts) with non-small cell lung cancer (nsclc) from the aries study: a bevacizumab (bv) treatment observational cohort study (ocs) [abstract 8040]. Proc Am Soc Clin Oncol 27:416s","journal-title":"Proc Am Soc Clin Oncol"},{"key":"9551_CR11","first-page":"e19001","volume":"27","author":"J Mezger","year":"2009","unstructured":"Mezger J, von Pawel J, Reck M (2009) Bevacizumab (Bv) single-agent maintenance following Bv-based chemotherapy in patients with advanced non-small cell lung cancer (nsclc): results from an exploratory analysis of the avail study [abstract e19001] Proc Am Soc. Clin Oncol 27:e19001","journal-title":"Clin Oncol"},{"key":"9551_CR12","doi-asserted-by":"crossref","first-page":"799s","DOI":"10.1200\/JCO.2008.18.9670","volume":"27","author":"V Miller","year":"2009","unstructured":"Miller V, O\u2019Connor P, Soh C, on behalf of the ATLAS Investigators (2009) A randomized, double-blind, placebo-controlled, phase iiib trial (atlas) comparing bevacizumab (b) therapy with or without erlotinib (e) after completion of chemotherapy with b for first-line treatment of locally advanced, recurrent, or metastatic non-small cell lung cancer (nsclc) [abstract LBA8002] Proc Am Soc. Clin Oncol 27:799s","journal-title":"Clin Oncol"},{"key":"9551_CR13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1040-8428(01)00179-2","volume":"43","author":"B Hildebrandt","year":"2002","unstructured":"Hildebrandt B, Wust P, Ahlers O et al (2002) The cellular and molecular basis of hyperthermia. Clin Rev Oncol Haemat 43:33\u201356","journal-title":"Clin Rev Oncol Haemat"},{"key":"9551_CR14","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/1471-2407-7-189","volume":"7","author":"Z Jiang","year":"2007","unstructured":"Jiang Z, Yan W, Ming J et al (2007) Docetaxel weekly regimen in conjunction with RF hyperthermia for pretreated locally advanced non-small cell lung cancer: a preliminary study. BMC Cancer 7:189","journal-title":"BMC Cancer"},{"key":"9551_CR15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/02656736.2010.500645","volume":"27","author":"H Shen","year":"2011","unstructured":"Shen H, Li XD, Wu CP et al (2011) The regimen of gemcitabine and cisplatin combined with radio frequency hyperthermia for advanced non-small cell lung cancer: a phase II study. Int J Hyperthermia 27:27\u201332","journal-title":"Int J Hyperthermia"},{"key":"9551_CR16","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s10147-006-0647-5","volume":"12","author":"M Mitsumori","year":"2007","unstructured":"Mitsumori M, Zeng ZF, Oliynychenko P et al (2007) Regional hyperthermia combined with radiotherapy for locally advanced non-small cell lung cancers: a multi-institutional prospective randomized trial of the International Atomic Energy Agency. Int J Clin Oncol 12:192\u2013198","journal-title":"Int J Clin Oncol"},{"key":"9551_CR17","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.lungcan.2010.06.007","volume":"71","author":"SD Moon","year":"2011","unstructured":"Moon SD, Ohguri T, Imada H et al (2011) Definitive radiotherapy plus regional hyperthermia with or without chemotherapy for superior sulcus tumors: a 20-year, single center experience. Lung Cancer 71:338\u2013343","journal-title":"Lung Cancer"},{"key":"9551_CR18","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/0265673021000017091","volume":"19","author":"K Sumiyoshi","year":"2003","unstructured":"Sumiyoshi K, Strebel FR, Rowe RW et al (2003) The effect of whole-body hyperthermia combined with \u2018metronomic\u2019 chemotherapy on rat mammary adenocarcinoma metastases. Int J Hyperthermia 19:103\u2013118","journal-title":"Int J Hyperthermia"},{"issue":"3A","key":"9551_CR19","first-page":"1819","volume":"20","author":"M Hermisson","year":"2000","unstructured":"Hermisson M, Weller M (2000) Hyperthermia enhanced chemosensitivity of human malignant glioma cells. Anticancer Res 20(3A):1819\u20131823","journal-title":"Anticancer Res"},{"key":"9551_CR20","volume-title":"Oncothermia \u2013principles and practices","author":"A Szasz","year":"2010","unstructured":"Szasz A, Szasz N, Szasz O (2010) Oncothermia \u2013principles and practices. Springer Verlag, Heidelberg"},{"key":"9551_CR21","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/RLU.0b013e3181b53a21","volume":"34","author":"L Chun-Yi","year":"2009","unstructured":"Chun-Yi L, Yiing-Feng H, Hua-Tzu H et al (2009) Lung cancer with solitary bone metastasis in the radius. Clin Nucl Med 34:684\u2013685","journal-title":"Clin Nucl Med"},{"key":"9551_CR22","first-page":"91","volume":"26","author":"WJ Shih","year":"1998","unstructured":"Shih WJ, Magoun S, Lahar B et al (1998) An unusual case of a tibial metastasis as the clinical presentation of bronchogenic adenocarcinoma. J Nucl Med Technol 26:91\u201393","journal-title":"J Nucl Med Technol."},{"key":"9551_CR23","volume-title":"et al","author":"SJ An","year":"2011","unstructured":"An SJ, Huang YS, Chen ZH (2011) et al. Posttreatment plasma VEGF levels may be associated with the overall survival of patients with advanced non-small cell lung cancer treated with bevacizumab plus chemotherapy, Med Oncol [Epub ahead of print]"},{"key":"9551_CR24","doi-asserted-by":"crossref","first-page":"6006","DOI":"10.1200\/JCO.2009.23.7545","volume":"27","author":"L Horn","year":"2009","unstructured":"Horn L, Dahlberg SE, Sandler AB et al (2009) Phase II study of cisplatin plus etoposide and bevacizumab for previously untreated, extensive-stage small-cell lung cancer: Eastern Cooperative Oncology Group Study E3501. J Clin Oncol 27:6006\u20136011","journal-title":"J Clin Oncol"},{"key":"9551_CR25","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/S0140-6736(11)60545-X","volume":"377","author":"RS Herbst","year":"2011","unstructured":"Herbst RS, Ansari R, Bustin F et al (2011) Efficacy of bevacizumab plus erlotinib versus erlotinib alone in advanced non-small-cell lung cancer after failure of standard first-line chemotherapy (BeTa): a double-blind, placebo-controlled, phase 3 trial. Lancet 377:1846\u20131854","journal-title":"Lancet"}],"container-title":["Pathology & Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-012-9551-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12253-012-9551-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-012-9551-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T06:39:21Z","timestamp":1559457561000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12253-012-9551-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,3]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["9551"],"URL":"https:\/\/doi.org\/10.1007\/s12253-012-9551-7","relation":{},"ISSN":["1219-4956","1532-2807"],"issn-type":[{"value":"1219-4956","type":"print"},{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,3]]}}}